Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemia

PURPOSE: The decision to re-induce patients with acute myeloid leukemia (AML) based on results of the day 14 bone marrow (BM) biopsy is variable and lacks evidence based data. The aim of our review was to evaluate the accuracy of a day 14 BM biopsy in determining the need for re-induction chemothera...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Morris, Tod A., DeCastro, Carlos M., Diehl, Louis F., Gockerman, Jon P., Lagoo, Anand S., Li, Zhiguo, Moore, Joseph O., Rizzieri, David A., Rao, Arati V.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3753071/
https://ncbi.nlm.nih.gov/pubmed/23046833
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2012.09.016
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados